NCT06170684View on ClinicalTrials.gov

Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Atypical Endometrial Hyperplasia and Endometrial Cancer
All Listed Sponsors
lead

Beijing Obstetrics and Gynecology Hospital

OTHER

NCT06170684 - Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer | Biotech Hunter | Biotech Hunter